Arius Formulations Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 15 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.16 Cr
- Satisfied Charges ₹ 8.00 M
- Revenue Growth -14.71%
- Profit Growth -32.15%
- Ebitda -24.93%
- Net Worth 17.19%
- Total Assets -4.35%
About Arius Formulations
Arius Formulations Private Limited (AFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 August 2009 and has a history of 15 years and six months. Its registered office is in Pondicherry, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹3.16 Cr. The company has closed loans amounting to ₹8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nataraj and Alamelu Nataraj serve as directors at the Company.
Company Details
-
Location
Pondicherry, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110TN2009PTC072482
-
Company No.
072482
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Aug 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Arius Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nataraj
|
Managing Director | 05-Aug-2009 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Alamelu Nataraj
|
Director | 05-Aug-2009 | Current |
Financial Performance of Arius Formulations.
Arius Formulations Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.71% decrease. The company also saw a substantial fall in profitability, with a 32.15% decrease in profit. The company's net worth Soared by an impressive increase of 17.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arius Formulations?
In 2022, Arius Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹31.60 M
₹8.00 M
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
- Vijaya Bank : 1.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2023 | Others | ₹3.36 M | Open |
| 03 Oct 2022 | Others | ₹1.66 Cr | Open |
| 20 Mar 2017 | Vijaya Bank | ₹7.00 M | Open |
| 26 Apr 2013 | Vijaya Bank | ₹0.64 M | Open |
| 05 Dec 2009 | Vijaya Bank | ₹4.00 M | Open |
How Many Employees Work at Arius Formulations?
Arius Formulations has a workforce of 14 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arius Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arius Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
